Nanorobot designed to improve immune cell recognition

Colorectal cancer is a common and challenging disease. While immunotherapy aims to boost the body's defences, it often falls short because immune cells struggle to reach and recognize tumours.

Now, researchers from Xinqiao Hospital and other Chinese institutes have developed a sophisticated "nanorobot" to tackle this issue. This tiny, biocompatible device is made of specialized peptides. It's designed to specifically find a protein called PD-L1, found on colorectal cancer cells.

When the nanorobot binds to PD-L1, it essentially disables the cancer's ability to hide from immune cells. Moreover, in the acidic environment of a tumour, the nanorobot assembles into structures that physically break open cancer cell membranes. This process not only directly attacks the tumour but also signals the immune system, drawing in T cells—critical immune fighters—to the site.

Initial tests in mice with colorectal tumours were highly successful. The nanorobot proved more effective than traditional chemotherapy and current immunotherapies, leading to significantly more T-cell infiltration into tumours and greater destruction of cancer cells, all with minimal harm to healthy tissues.

This innovative nanorobot represents a major leap forward, potentially opening new avenues for more powerful and precise colorectal cancer treatments in the future.



Reference
by Ingrid Fadelli, A new nanorobot designed to improve immune cell recognition could help treat colorectal cancer
1 phys.org  Available at https://phys.org/news/2026-01-nanorobot-immune-cell-recognition-colorectal.html
(Assessed: 20th January 2026)